Related Experiment Videos
[Cost aspects of oncologic chemotherapy]
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|May 2, 1989
Summary
Analyzing chemotherapy costs from 1983-1985, this study found drug expenses constitute about 50% of total cancer chemotherapy costs. Avoiding hospitalization could reduce overall expenses by over 30%.
Area of Science:
- Oncology
- Health Economics
Context:
- Chemotherapy represents a significant expenditure in cancer treatment.
- Understanding the cost components of chemotherapy is crucial for healthcare management and patient affordability.
- This study retrospectively analyzed chemotherapy costs incurred by patients between 1983 and 1985.
Purpose:
- To analyze the total monthly costs of chemotherapy for both outpatients and inpatients.
- To determine the proportion of drug costs within overall chemotherapy expenses.
- To explore potential cost-saving strategies, such as avoiding hospitalization.
Summary:
- Total monthly chemotherapy costs varied significantly, ranging from SFr. 379 to SFr. 6065 for outpatients and SFr. 874 to SFr. 3476 for inpatients.
- Drug costs accounted for approximately 50% of total chemotherapy expenses, with higher costs observed for curative therapies compared to palliative ones.
- Avoiding hospitalization could potentially reduce total costs by over 30%, though this may not be feasible for all patients.
Impact:
- Provides insights into historical chemotherapy cost structures, highlighting the significant contribution of drug expenses.
- Suggests that outpatient chemotherapy administration could be a cost-effective strategy.
- Acknowledges limitations in cost analysis, excluding indirect costs like loss of earnings and state-borne deficits.